1 |
Simmler, L. D., Buser, T. A., Donzelli, M., Schramm, Y., Dieu, L. H., Huwyler, J., Chaboz, S., Hoener, M. C. and Liechti, M. E. : Pharmacological characterization of designer cathinones in vitro. Br. J. Pharmacol. 168, 458 (2013).
DOI
ScienceOn
|
2 |
Dal Cason, T. A., Young, R. and Glennon, R. A. : Cathinone: an investigation of several N-alkyl and methylenedioxy-substituted analogs. Pharmacol. Biochem. Behav. 58, 1109 (1997).
DOI
ScienceOn
|
3 |
Varmuza, K., Dehmer, M. and Bonchev, D. : Statistical Modelling of Molecular Descriptors in QSAR/QSPR, Wiley- Blackwell, Weinheim (2012).
|
4 |
Golbraikh, A. and Tropsha, A. : Beware of q2!. J. Mol. Graph Model. 20, 269 (2002).
DOI
ScienceOn
|
5 |
Shen, M., Xiao, Y., Golbraikh, A., Gombar, V. K. and Tropsha, A. : Development and validation of k-nearest-neighbor QSPR models of metabolic stability of drug candidates. J. Med. Chem. 46, 3013 (2003).
DOI
ScienceOn
|
6 |
Guidance Document on the validation of (Quantitative) Structure-Activity Relationship [(Q)SAR] Models, OECD, (2007) [Accessed 08/11 2013].
|
7 |
2011年8月2日 藥事.食品衛生審議會 指定藥物部議事會, 厚生労働省, (2011) [Accessed 07/11 2013].
|
8 |
European Commission takes decisive action against legal highs, EC (2013) [Accessed 17/09 2013].
|
9 |
관세청, 신종마약과의 전쟁 선포, 관세청, (2012) [Accessed 25/06 2012].
|
10 |
의약품등의 의존성 평가지침, 식품의약품안전처 (2012) [Accessed 30/05 2012].
|
11 |
Kurihara, M. : Computational study on prediction of bioactivity for regulation of new designer drugs. Yakugaku Zasshi 133, 13 (2013).
DOI
ScienceOn
|
12 |
Bhusan, K : EasyQSAR 1.0 [Accessed 23/07 2012].
|